RESCUE-ESE identifies candidate exonic splicing enhancers in vertebrate exons
1 Center for Cancer Research, 2 Department of Biology and 5 McGovern Institute, Massachusetts Institute of Technology, Cambridge, MA 02139, USA, 3 Department of Epidemiology and Biostatistics, University of California San Francisco, 500 Parnassus Avenue Box 0560, San Francisco, CA 94143-0560, USA and 4 46 Glenbrook Road, W. Hartford, CT 06107, USA
* To whom correspondence should be addressed. Tel: +1 617 258 5997; Fax: +1 617 452 2936; Email: cburge{at}mit.edu
Received February 13, 2004; Revised and Accepted March 24, 2004
| ABSTRACT |
|---|
|
|
|---|
A typical gene contains two levels of information: a sequence that encodes a particular protein and a host of other signals that are necessary for the correct expression of the transcript. While much attention has been focused on the effects of sequence variation on the amino acid sequence, variations that disrupt gene processing signals can dramatically impact gene function. A variation that disrupts an exonic splicing enhancer (ESE), for example, could cause exon skipping which would result in the exclusion of an entire exon from the mRNA transcript. RESCUE-ESE, a computational approach used in conjunction with experimental validation, previously identified 238 candidate ESE hexamers in human genes. The RESCUE-ESE method has recently been implemented in three additional species: mouse, zebrafish and pufferfish. Here we describe an online ESE analysis tool (http://genes.mit.edu/burgelab/rescue-ese/) that annotates RESCUE-ESE hexamers in vertebrate exons and can be used to predict splicing phenotypes by identifying sequence changes that disrupt or alter predicted ESEs.
| INTRODUCTION |
|---|
|
|
|---|
The splicing machinery requires the presence of several cis-acting sequence elements to accurately recognize and remove introns from pre-mRNA. While the splice sites themselves are located in the introns, additional sequences that enhance splicing from an exonic location are also known. These exonic splicing enhancers (ESEs) are short oligonucleotide sequences that occur frequently in both constitutively and alternatively spliced exons (15). ESEs are often recognized by proteins of the SR family, which function by recruiting components of the core splicing machinery to nearby splice sites (6) or by counteracting the effects of nearby silencing elements (7).
A variety of selection schemes have been used to determine which sequences are capable of functioning as ESEs (25). These SELEX methods start with a complex pool of random sequence and invoke an iterative selectionamplification protocol which progressively enriches the fraction of molecules in the total pool that possess ESE activity. Functional SELEX experiments, performed in vitro, have described the binding specificity of four SR proteins, and these motifs have been incorporated into an online ESE annotation tool called ESEFinder (8).
Previously, we reported a computational method, RESCUE-ESE, which identifies ESEs in human genomic sequences by searching for hexanucleotides that satisfy the following two criteria: (i) they are significantly enriched in human exons relative to introns, and (ii) they are significantly more frequent in exons with weak (non-consensus) splice sites than in exons with strong (consensus) splice sites (1). This method identified a set of 238 hexamers (of the 4096 possible hexamers) that were clustered into 10 groups: two groups of 5'ss ESEs, five groups of 3'ss ESEs and three additional groups that appear to be common to both the 3'ss and 5'ss (Figure 1A, B). In vivo tests of splicing enhancer activity, performed on 10 test sequences that were chosen to represent each of the 10 non-redundant ESE motifs (Figure 1), confirmed activity in all 10 cases, and point mutations that were chosen to disrupt the predicted ESE hexamer within the test sequence reduced exon inclusion by more than 2-fold in 9 of the 10 cases (1).
|
The importance of considering the possibility of RNA-processing phenotypes in the analysis of mutations has been emphasized by the growing list of exonic variations that cause or modify disease without altering the amino acid sequence of the protein [see the list of 23 disease genes reviewed in (9)]. While these particular variations were implicated in exon skipping, pre-mRNA processing phenotypes are assayed infrequently, and many other synonymous mutations detected in genetic screens and presumed to be neutral may also turn out to have splicing phenotypes.
In order to facilitate the analysis of point mutations we have created an online ESE annotation tool (http://genes.mit.edu/burgelab/rescue-ese/). The predictive power of the set of RESCUE-ESE hexamers used on this server was previously demonstrated on a set of published mutations that cause exon skipping in the human HPRT gene. About one-half of the base changes found in the set of splicing mutants completely eliminated RESCUE-predicted ESEs from the wild-type HPRT sequence (1). It has also been inferred, from a large-scale analysis of the single nucleotide polymorphism database, that natural selection has eliminated approximately one-fifth of all mutations that disrupt RESCUE-predicted ESEs, further supporting the idea that predicted ESEs are frequently functional in human genes (W. G. Fairbrother, D. Holste, C. B. Burge and P. A. Sharp, submitted for publication).
Repeating the RESCUE-ESE protocol on different species revealed substantial overlap between hexamers predicted to be ESEs in vertebrates (G. W. Yeo, S. Hoon, B. Venkatesh and C. B. Burge, submitted for publication). Approximately three-quarters of the human RESCUE-ESE set (172 hexamers) were also predicted as ESEs in mouse. About one-third of human ESEs (73 hexamers) are also predicted to have ESE activity in human, mouse and fish. This smaller core set of hexamers tended to be purine rich and to resemble the classical GAR motif. Additional analysis revealed that most of the hexamers that were predicted to be ESEs in humans had similar, non-uniform, distribution across exons in datasets derived from three additional vertebrate species (mouse, zebrafish and pufferfish). The density of ESEs along vertebrate exons increases near the 3'ss and 5'ss (W. G. Fairbrother, D. Holste, C. B. Burge and P. A. Sharp, submitted for publication; G. W. Yeo, S. Hoon, B. Venkatesh and C. B. Burge, submitted for publication). Taken together, this work argues that the predicted ESEs are functional sequences that have been conserved throughout the vertebrate lineage and will be useful in the analysis of mutations in several species.
| DESCRIPTION |
|---|
|
|
|---|
The entry page to the RESCUE-ESE server contains a brief description of the RESCUE-ESE method and the details of how particular ESEs were experimentally validated (Figure 2). The web server allows a sequence to be checked for presence of candidate ESE hexamers. A text file containing the non-redundant list of 238 human ESEs can be downloaded from the entry page. An input sequence can be pasted directly into the window or uploaded in multi-FASTA format and annotated with the ESEs from the selected species (human, mouse, pufferfish and zebrafish are the currently available options).
|
The server is case insensitive and accepts either DNA (T) or RNA (U) sequences as input (up to 4 kb in length). Although ambiguous nucleotides (e.g. R, Y or N) are accepted, the program will not predict ESE hexamers that overlap these positions. The effect of sequence variation on ESEs can be analyzed by entering both the wild type and variant sequence into the input window as two sequences in FASTA format. This application is illustrated (in Figure 2A) with an A to T mutation in the HPRT gene that disrupts six RESCUE-ESE hexamers (Figure 2B) and is known to cause exon skipping (Fairbrother et al., submitted for publication). ESEs are annotated on an output page as yellow hexamers drawn above the white input sequence against a dark-blue background (Figure 2B).
| DISCUSSION |
|---|
|
|
|---|
Since ESE disruption or alteration carries with it the potential to cause disease, effective ESE annotation will be useful in analyzing sequence variation. Mutations that are analyzed in this manner can fall into one of four categories: (i) ESE disruption, where one or more predicted ESE hexamers present in the wild-type sequence are disrupted by the mutation; (ii) ESE alteration, where ESEs are present in both the wild-type and mutant version of the sequence; (iii) ESE neutral, where ESEs are present in neither the wild-type nor mutant sequence and (iv) ESE creation, where predicted ESE hexamers are present in the mutant but not wild-type sequence. While the relatively small number of mutations that have been discovered within an exon (at least 5 nt from the splice site) and shown to be associated with exon skipping limits our ability to measure the sensitivity of ESE annotation, about one-half of the known exon skipping mutants in the human HPRT gene were classified as ESE disruption mutations by our method. This value is approximately three times higher than would be expected by chance [P < 0.01 (1)]. Conversely, ESE disruption events were found to be under-represented within the public database of human single nucleotide polymorphisms (dbSNP), a set of variations that is presumed to be predominantly selectively neutral (W. G. Fairbrother, D. Holste, C. B. Burge and P. A. Sharp, submitted for publication). The annotation of SNPs revealed that both ESE disruption events and, to a lesser degree, ESE alteration events were selected against in the human population. This result suggests that both ESE disruption and ESE alteration mutations could alter splicing phenotypes. By this criterion, RESCUE-ESE hexamers would correctly predict a splicing defect in 53% of the exonic mutations in HPRT that are associated with exon skipping.
While the analysis of known splicing mutants suggests a sensitivity of at least 50%, a quantitative measure of specificity is more elusive. Without studying the splicing phenotypes of a large number of exonic mutations, it is difficult to reliably determine the true incidence of ESE disruption within the set of mutations predicted to disrupt ESEs. Site-directed mutagenesis studies designed to disrupt predicted ESEs in wild-type exonic sequences reduced splicing in vivo for 9 of the 10 cases tested in a splicing reporter construct (1). While 90% of these ESE disruption mutations reduced splicing in a reporter system, our recent analysis of natural variations (SNPs) in human exons suggested that only
20% are eliminated by natural selection. This selection was much stronger (
50%) for mutations located within 25 nt of splice sites (Fairbrother et al., submitted for publication). These differences suggest, (i) a small amount of exon skipping may be tolerated in certain genes/exons and (ii) that the specificity of splicing phenotype predictions based on RESCUE-ESE annotations would be higher for mutations that fall near splice sites. In addition to the location of an ESE within an exon, there are other external variables that could modulate the function of an ESE. Context effects, such as secondary structure or adjacent negative elements, could limit the accessibility and, hence, activity of a predicted ESE in a particular location.
An additional benefit of a computational approach such as RESCUE-ESE is that it can be readily implemented in other genomes as they become available. We present a tool capable of annotating ESEs from several species. This allows the user to identify elements that can function as ESEs across several species. This feature may facilitate ESE analysis in other organisms, ensure the correct processing of fish or human genes in transgenic mice or serve as an indicator of predicted ESE quality. Although representative hexamers were found to have ESE activity in an in vivo splicing assay, some fraction of the candidate ESE hexamers are likely to be false positives of the RESCUE method. While it is possible that certain recognition sequences could be restricted to particular lineages, hexamers that are predicted to be ESEs in several species are very likely to have a lower false positive rate than species-specific ESEs. In summary, we expect that this cross-species approach will provide useful insight into the functional relevance of gene processing signals. We plan to add other species options (such as Drosophila melanogaster and Carnorhabditis elegans) to the server as we complete our ESE analysis of additional species.
| Notes |
|---|
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated.
| REFERENCES |
|---|
|
|
|---|
- Fairbrother,W.G., Yeh,R.F., Sharp,P.A. and Burge,C.B. ( (2002) ) Predictive identification of exonic splicing enhancers in human genes. Science, , 297, , 10071013.
[Abstract/Free Full Text] - Liu,H.X., Zhang,M. and Krainer,A.R. ( (1998) ) Identification of functional exonic splicing enhancer motifs recognized by individual SR proteins. Genes Dev., , 12, , 19982012.
[Abstract/Free Full Text] - Tian,H. and Kole,R. ( (1995) ) Selection of novel exon recognition elements from a pool of random sequences. Mol. Cell Biol., , 15, , 62916298.[Abstract]
- Schaal,T.D. and Maniatis,T. ( (1999) ) Selection and characterization of pre-mRNA splicing enhancers: identification of novel SR protein-specific enhancer sequences. Mol. Cell Biol., , 19, , 17051719.
[Abstract/Free Full Text] - Coulter,L.R., Landree,M.A. and Cooper,T.A. ( (1997) ) Identification of a new class of exonic splicing enhancers by in vivo selection. Mol. Cell Biol., , 17, , 21432150.[Abstract]
- Graveley,B.R. ( (2000) ) Sorting out the complexity of SR protein functions. RNA, , 6, , 11971211.[CrossRef][Web of Science][Medline]
- Kan,J.L. and Green,M.R. ( (1999) ) Pre-mRNA splicing of IgM exons M1 and M2 is directed by a juxtaposed splicing enhancer and inhibitor. Genes Dev., , 13, , 462471.
[Abstract/Free Full Text] - Cartegni,L., Wang,J., Zhu,Z., Zhang,M.Q. and Krainer,A.R. ( (2003) ) ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res., , 31, , 35683571.
[Abstract/Free Full Text] - Cartegni,L., Chew,S.L. and Krainer,A.R. ( (2002) ) Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nature Rev. Genet., , 3, , 285298.[CrossRef][Web of Science][Medline]
- Valentine, C.R. ( (1998) ) The association of nonsense codons with exon skipping. Mutat. Res., , 411, , 87117.[CrossRef][Web of Science][Medline]
This article has been cited by other articles:
![]() |
Z. Xu and J. A. Taylor SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies Nucleic Acids Res., July 1, 2009; 37(suppl_2): W600 - W605. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-O. Desmet, D. Hamroun, M. Lalande, G. Collod-Beroud, M. Claustres, and C. Beroud Human Splicing Finder: an online bioinformatics tool to predict splicing signals Nucleic Acids Res., May 1, 2009; 37(9): e67 - e67. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Bourbon, M A Duarte, A C Alves, A M Medeiros, L Marques, and A K Soutar Genetic diagnosis of familial hypercholesterolaemia: the importance of functional analysis of potential splice-site mutations J. Med. Genet., May 1, 2009; 46(5): 352 - 357. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Coles, M. Hallegger, and C. W.J. Smith A nonsense exon in the Tpm1 gene is silenced by hnRNP H and F RNA, January 1, 2009; 15(1): 33 - 43. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Karchin Next generation tools for the annotation of human SNPs Brief Bioinform, January 1, 2009; 10(1): 35 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. N. Hutchins, S. M. Murphy, P. Singh, and J. H. Graber Position-dependent motif characterization using non-negative matrix factorization Bioinformatics, December 1, 2008; 24(23): 2684 - 2690. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-i. Takeda, Y. Suzuki, R. Sakate, Y. Sato, M. Seki, T. Irie, N. Takeuchi, T. Ueda, M. Nakao, S. Sugano, et al. Low conservation and species-specific evolution of alternative splicing in humans and mice: comparative genomics analysis using well-annotated full-length cDNAs Nucleic Acids Res., November 1, 2008; 36(20): 6386 - 6395. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Iacobucci, A. Lonetti, F. Messa, D. Cilloni, F. Arruga, E. Ottaviani, S. Paolini, C. Papayannidis, P. P. Piccaluga, P. Giannoulia, et al. Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: implications for a new mechanism of resistance Blood, November 1, 2008; 112(9): 3847 - 3855. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Goina, N. Skoko, and F. Pagani Binding of DAZAP1 and hnRNPA1/A2 to an Exonic Splicing Silencer in a Natural BRCA1 Exon 18 Mutant Mol. Cell. Biol., June 1, 2008; 28(11): 3850 - 3860. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Robins, M. Krasnitz, and A. J. Levine The Computational Detection of Functional Nucleotide Sequence Motifs in the Coding Regions of Organisms Experimental Biology and Medicine, June 1, 2008; 233(6): 665 - 673. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Vela, J. M. Hilari, X. Roca, A. M. Munoz-Marmol, A. Ariza, and M. Isamat Multisite and bidirectional exonic splicing enhancer in CD44 alternative exon v3 RNA, December 1, 2007; 13(12): 2312 - 2323. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Warnecke and L. D. Hurst Evidence for a Trade-Off between Translational Efficiency and Splicing Regulation in Determining Synonymous Codon Usage in Drosophila melanogaster Mol. Biol. Evol., December 1, 2007; 24(12): 2755 - 2762. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kralovicova and I. Vorechovsky Global control of aberrant splice-site activation by auxiliary splicing sequences: evidence for a gradient in exon and intron definition Nucleic Acids Res., October 8, 2007; 35(19): 6399 - 6413. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Graber, J. Salisbury, L. N. Hutchins, and T. Blumenthal C. elegans sequences that control trans-splicing and operon pre-mRNA processing RNA, September 1, 2007; 13(9): 1409 - 1426. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Parmley and L. D. Hurst Exonic Splicing Regulatory Elements Skew Synonymous Codon Usage near Intron-exon Boundaries in Mammals Mol. Biol. Evol., August 1, 2007; 24(8): 1600 - 1603. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhu, H. M. Tucker, K. E. Grear, J. F. Simpson, A. K. Manning, L. A. Cupples, and S. Estus A common polymorphism decreases low-density lipoprotein receptor exon 12 splicing efficiency and associates with increased cholesterol Hum. Mol. Genet., July 15, 2007; 16(14): 1765 - 1772. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. I. Dogan, L. Getoor, W. J. Wilbur, and S. M. Mount SplicePort--An interactive splice-site analysis tool Nucleic Acids Res., July 13, 2007; 35(suppl_2): W285 - W291. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ryman, N. Fong, E. Bratt, D. L. Bentley, and M. Ohman The C-terminal domain of RNA Pol II helps ensure that editing precedes splicing of the GluR-B transcript RNA, July 1, 2007; 13(7): 1071 - 1078. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Lee, Y. Lee, B. Kim, Y. Shin, S. Nam, P. Kim, N. Kim, W.-H. Chung, J. Kim, and S. Lee ECgene: an alternative splicing database update Nucleic Acids Res., January 12, 2007; 35(suppl_1): D99 - D103. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. K. Tran, Y. Takeshima, Z. Zhang, M. Yagi, A. Nishiyama, Y. Habara, and M. Matsuo Splicing analysis disclosed a determinant single nucleotide for exon skipping caused by a novel intraexonic four-nucleotide deletion in the dystrophin gene J. Med. Genet., December 1, 2006; 43(12): 924 - 930. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Bhatti, D. M. Church, J. L. Rutter, J. P. Struewing, and A. J. Sigurdson Candidate Single Nucleotide Polymorphism Selection using Publicly Available Tools: A Guide for Epidemiologists Am. J. Epidemiol., October 15, 2006; 164(8): 794 - 804. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-i. Takeda, Y. Suzuki, M. Nakao, R. A. Barrero, K. O. Koyanagi, L. Jin, C. Motono, H. Hata, T. Isogai, K. Nagai, et al. Large-scale identification and characterization of alternative splicing variants of human gene transcripts using 56 419 completely sequenced and manually annotated full-length cDNAs Nucleic Acids Res., September 1, 2006; 34(14): 3917 - 3928. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Buratti, M. Baralle, and F. E. Baralle Defective splicing, disease and therapy: searching for master checkpoints in exon definition Nucleic Acids Res., July 19, 2006; 34(12): 3494 - 3510. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-Y. Yuan, J.-J. Chiou, W.-H. Tseng, C.-H. Liu, C.-K. Liu, Y.-J. Lin, H.-H. Wang, A. Yao, Y.-T. Chen, and C.-N. Hsu FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res., July 1, 2006; 34(Web Server issue): W635 - W641. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Spena, M. L. Tenchini, and E. Buratti Cryptic splice site usage in exon 7 of the human fibrinogen B{beta}-chain gene is regulated by a naturally silent SF2/ASF binding site within this exon RNA, June 1, 2006; 12(6): 948 - 958. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhong, J. R. Liu, J. W. Kyle, D. A. Hanck, and W. S. Agnew A profile of alternative RNA splicing and transcript variation of CACNA1H, a human T-channel gene candidate for idiopathic generalized epilepsies Hum. Mol. Genet., May 1, 2006; 15(9): 1497 - 1512. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Schattner and M. Diekhans Regions of extreme synonymous codon selection in mammalian genes Nucleic Acids Res., March 23, 2006; 34(6): 1700 - 1710. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. P. Belancio, D. J. Hedges, and P. Deininger LINE-1 RNA splicing and influences on mammalian gene expression Nucleic Acids Res., March 22, 2006; 34(5): 1512 - 1521. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-N. Grellscheid and C. W. J. Smith An Apparent Pseudo-Exon Acts both as an Alternative Exon That Leads to Nonsense-Mediated Decay and as a Zero-Length Exon. Mol. Cell. Biol., March 1, 2006; 26(6): 2237 - 2246. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Florea Bioinformatics of alternative splicing and its regulation Brief Bioinform, March 1, 2006; 7(1): 55 - 69. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-C. Chen, S.-S. Wang, C.-J. Chen, W.-H. Li, and T.-J. Chuang Alternatively and Constitutively Spliced Exons Are Subject to Different Evolutionary Forces Mol. Biol. Evol., March 1, 2006; 23(3): 675 - 682. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Parmley, J. V. Chamary, and L. D. Hurst Evidence for Purifying Selection Against Synonymous Mutations in Mammalian Exonic Splicing Enhancers Mol. Biol. Evol., February 1, 2006; 23(2): 301 - 309. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Akerman and Y. Mandel-Gutfreund Alternative splicing regulation at tandem 3' splice sites Nucleic Acids Res., January 3, 2006; 34(1): 23 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Robins, M. Krasnitz, H. Barak, and A. J. Levine A Relative-Entropy Algorithm for Genomic Fingerprinting Captures Host-Phage Similarities J. Bacteriol., December 15, 2005; 187(24): 8370 - 8374. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Baralle and M Baralle Splicing in action: assessing disease causing sequence changes J. Med. Genet., October 1, 2005; 42(10): 737 - 748. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, P. J. Smith, A. R. Krainer, and M. Q. Zhang Distribution of SR protein exonic splicing enhancer motifs in human protein-coding genes Nucleic Acids Res., September 7, 2005; 33(16): 5053 - 5062. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. de la Grange, M. Dutertre, N. Martin, and D. Auboeuf FAST DB: a website resource for the study of the expression regulation of human gene products Nucleic Acids Res., July 28, 2005; 33(13): 4276 - 4284. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Minovitsky, S. L. Gee, S. Schokrpur, I. Dubchak, and J. G. Conboy The splicing regulatory element, UGCAUG, is phylogenetically and spatially conserved in introns that flank tissue-specific alternative exons Nucleic Acids Res., February 3, 2005; 33(2): 714 - 724. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. MOHN, M. BUHLER, and O. MUHLEMANN Nonsense-associated alternative splicing of T-cell receptor {beta} genes: No evidence for frame dependence RNA, February 1, 2005; 11(2): 147 - 156. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. BUHLER and O. MUHLEMANN Alternative splicing induced by nonsense mutations in the immunoglobulin {micro} VDJ exon is independent of truncation of the open reading frame RNA, February 1, 2005; 11(2): 139 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Yeo, S. Hoon, B. Venkatesh, and C. B. Burge Variation in sequence and organization of splicing regulatory elements in vertebrate genes PNAS, November 2, 2004; 101(44): 15700 - 15705. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||














